Benchmark Holdings plc (AIM: BMK)

Market Cap	310.71M
Revenue (ttm)	147.51M
Net Income (ttm)	-33.24M
Shares Out	739.79M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	25.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,040
Open	41.84
Previous Close	42.00
Day's Range	41.09 - 41.84
52-Week Range	33.15 - 48.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About Benchmark Holdings

Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquac...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 823
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: BMK

Financial Performance

In 2023, Benchmark Holdings's revenue was 169.48 million, an increase of 7.46% compared to the previous year's 157.71 million. Losses were -23.15 million, -27.86% less than in 2022.